SLITRK5 is a cellular protein whose normal function appears to suppress bone formation and could be a potential new target for the treatment ofosteoporosis, according to a collaborative study conducted by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Cells manifesting the SLITRK5 protein are marked with magenta (left) and a bone-forming osteoblast marker in green (center). These markers were observed in the cancellous bone in the medulla space (top) or on the outer layer covering the bone (bottom). The overlap between these two markers (right) shows that SLITRK5 is found in bone-forming osteoblasts but not in other cell types, helping to make SLITRK5 a target for skeletal disease treatment. Credit: Dr. Matthew Greenblatt and Dr. Jun Sun
There Research was published in the scientific journal Nature Communications.
Read Also
- The Lord of the Rings the Lord of Television. The first series of the series is to cost $ 465 million Apr 20, 2021
- Video conferencing : Microsoft Teams will be based on Zoom Jun 4, 2020
- Tension in Portugal: The cold greeting between Cristiano Ronaldo and Bruno Fernandes after their statements against Manchester United Nov 15, 2022
- Figure, New York Community team up on blockchain projects Aug 16, 2021
- Transport A container that fell off a truck ride closed the lane for hours in Hietalahdenranta, Helsinki Jul 3, 2021
- Jean Paul Santa María speaks after leaving La voz Perú: “It was a fair elimination” Jul 25, 2021
- Sextape blackmail in Saint-Étienne: Justice prohibits Mediapart from publishing new revelations Nov 22, 2022